Search
Bicalutamide
go.drugbank.com/drugs/DB01128ApprovedInvestigationalBicalutamide is an oral non-steroidal anti-androgen for prostate cancer. It is comprised of a racemic mixture that is a 50:50 composition of the (R)-bicalutamide and (S)-bicalutamide enantionmers.
Categories: Hormones and Related Agents, leuprorelin and bicalutamideProducts: Van-bicalutamide, Ran-bicalutamideWater
go.drugbank.com/drugs/DB09145ApprovedInvestigationalWater is a liquid at standard ambient temperature and pressure, but it often co-exists on Earth with its solid state, ice; and gaseous state, steam (water vapor). … As a chemical compound, a water molecule contains one oxygen and two hydrogen atoms that are connected by covalent bonds.
Mixtures: Protropin Inj Pws 10mg/vial, Protropin - Kit Im Sc 10mg/vialProducts: TACEX-IM, Xpect First aid Buffered Eye and SkinGlyburide
go.drugbank.com/drugs/DB01016ApprovedInvestigational[L8123] Glyburide stimulates insulin secretion through the closure of ATP-sensitive potassium channels on beta cells, raising intracellular potassium and calcium ion concentrations. … Glyburide is a second generation sulfonylurea used to treat patients with diabetes mellitus type II.
Mixtures: GLUCOMIN-G 500MG/5MG TABLET, GLUCOMIN-G 500MG/2.5MG TABLETCategories: Alimentary Tract and Metabolism, Drugs Used in DiabetesFelis catus hair
go.drugbank.com/drugs/DB10499ApprovedInvestigationalDomestic cat hair is used in allergenic testing.
Synonyms: Cat hair, Cat hair extractProducts: Standardized Cat Hair, Cat Hair, StandardizedVenlafaxine
go.drugbank.com/drugs/DB00285ApprovedInvestigationalVenlafaxine is an antidepressant and a serotonin and norepinephrine reuptake inhibitor (SNRI). … [L43030] The immediate formulation of the drug, marketed as Effexor, was first approved by the FDA in 1993 and the extended-release formulation, Effexor XR, was later introduced in 1997.
Categories: Serotonin and Noradrenaline Reuptake InhibitorsProducts: VENXOR 50MG TABLET, Effexor Tablets, 50mgOfloxacin
go.drugbank.com/drugs/DB01165ApprovedInvestigationalA synthetic fluoroquinolone (fluoroquinolones) antibacterial agent that inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
Categories: ofloxacin and ornidazole, Topoisomerase II InhibitorsProducts: Liq 20mg/ml, ROFLOXAN 200MG/100ML IV INFÜZYON IÇIN ÇÖZELTI IÇEREN FLAKONSecukinumab
go.drugbank.com/drugs/DB09029ApprovedInvestigational[A249840] Following its first global approval in Japan in December 2014, secukinumab was approved by the European Commission on January 15, 2015, and by the FDA a few days after (January 21, 2015). … [A249805] It is currently approved to treat a number of chronic inflammatory conditions, such as plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and hidradenitis suppurativa.
Categories: Amino Acids, Peptides, and Proteins, Antineoplastic and Immunomodulating AgentsProducts: COSENTYX SOLUTION FOR INJECTION IN PREFILLED SYRINGE 75MG/0.5ML, COSENTYX SOLUTION FOR INJECTION IN PREFILLED SYRINGE 150MG/MLBenzatropine
go.drugbank.com/drugs/DB00245ApprovedInvestigational[A37914] Benztropine was developed by USL Pharma and officially approved by the FDA on 1996.[L5500] … The generation of structure-activity relationships proved that benztropine derivatives with the presence of a chlorine substituent in the para position in one of the phenyl rings produces an increased
Products: Cogentin Inj 1mg/ml, TICOLIN 2 MG/2 ML IM/IV ENJEKSIYONLUK ÇÖZELTI IÇEREN AMPUL,1 ADETVerapamil
go.drugbank.com/drugs/DB00661ApprovedInvestigational[A188514] It is a member of the non-dihydropyridine class of calcium channel blockers, which includes drugs like [diltiazem] and [flunarizine], but is chemically unrelated to other cardioactive medications … greater potency than the R-enantiomer, but is metabolized at a higher rate.
Mixtures: TARKA 180MG/2MG, TARKA 180MG/2MGCategories: Verapamil and analogues, trandolapril and verapamilMycophenolate mofetil
go.drugbank.com/drugs/DB00688ApprovedInvestigational[L7363] It is marketed by Roche Pharmaceuticals and was granted FDA approval for the prophylaxis of transplant rejection in 1995. … [A180799,A180805] Previously, mycophenolic acid (MPA) was administered to individuals with autoimmune diseases beginning in the 1970s, but was discontinued due to gastrointestinal effects and concerns
Categories: Mycophenolic Acid and ProdrugsProducts: MYFENAX 250MG, CELLCEPT 250MG